IL105475A - PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS - Google Patents
PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSISInfo
- Publication number
- IL105475A IL105475A IL105475A IL10547593A IL105475A IL 105475 A IL105475 A IL 105475A IL 105475 A IL105475 A IL 105475A IL 10547593 A IL10547593 A IL 10547593A IL 105475 A IL105475 A IL 105475A
- Authority
- IL
- Israel
- Prior art keywords
- dehydro
- dihydroxy
- vitamin
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- 208000001132 Osteoporosis Diseases 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
- A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US87337492A | 1992-04-24 | 1992-04-24 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL105475A0 IL105475A0 (en) | 1993-08-18 |
| IL105475A true IL105475A (en) | 1997-06-10 |
Family
ID=25361517
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL105475A IL105475A (en) | 1992-04-24 | 1993-04-21 | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US5395830A (de) |
| EP (1) | EP0567352B1 (de) |
| JP (1) | JP2769960B2 (de) |
| KR (1) | KR940005275A (de) |
| AT (1) | ATE135220T1 (de) |
| AU (1) | AU666529B2 (de) |
| CA (1) | CA2094424C (de) |
| DE (1) | DE69301750T2 (de) |
| IL (1) | IL105475A (de) |
| NZ (1) | NZ247406A (de) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20040009958A1 (en) * | 1991-01-08 | 2004-01-15 | Bone Care International, Inc. | Methods for preparation and use of 1alpha,24(S)-dihydroxyvitamin D2 |
| US5661140A (en) * | 1994-11-21 | 1997-08-26 | Wisconsin Alumni Research Foundation | 18-nor-vitamin D compounds |
| US5716946A (en) * | 1996-02-13 | 1998-02-10 | Wisconsin Alumni Research Foundation | Multiple sclerosis treatment |
| KR100474517B1 (ko) * | 1997-10-27 | 2005-07-21 | 삼성전자주식회사 | 엘씨디패널절단장치 |
| US6479474B2 (en) * | 1999-07-08 | 2002-11-12 | Wisconsin Alumni Research Foundation | Dietary calcium as a supplement to vitamin D compound treatment of multiple sclerosis |
| WO2001022934A2 (en) * | 1999-09-24 | 2001-04-05 | Yng Wong Quing Non | Delivery of small doses of ingestible treatments |
| US7888338B2 (en) * | 2004-12-06 | 2011-02-15 | K.U. Leuven Research & Development | 7-(2-cyclohexylidene-ethylidene)-spiro[4.5]decanes |
| CN101400263B (zh) | 2006-03-10 | 2012-10-03 | 帝斯曼知识产权资产管理有限公司 | 苯甲酸或其衍生物在制造营养药物组合物中的用途 |
| CA2981549A1 (en) * | 2009-01-27 | 2010-08-05 | Berg Llc | Vitamin d3 and analogs thereof for alleviating side effects associated with chemotherapy |
| CN106265695B (zh) | 2009-08-14 | 2021-05-07 | 博格有限责任公司 | 用于治疗脱发的维生素d3及其类似物 |
| CN112156097A (zh) | 2013-05-29 | 2021-01-01 | 博格有限责任公司 | 使用维生素d预防或减轻化疗诱发的脱发 |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3833622A (en) * | 1969-03-17 | 1974-09-03 | Upjohn Co | Crystalline 25-hydroxycholecalciferol hydrate and structurally related compounds |
| US3901928A (en) * | 1973-01-10 | 1975-08-26 | Robert Henry Hesse | 1' ,3' -dihydroxy steroid-5-enes method of preparing same and their use for preparing 1' -hydroxy-25-hydrogen vitamin d compounds |
| US4260549A (en) * | 1979-05-21 | 1981-04-07 | Wisconsin Alumni Research Foundation | Process for preparing 1α-hydroxylated compounds |
| US4267117A (en) * | 1978-06-19 | 1981-05-12 | The Upjohn Company | Compounds and process |
| US4255596A (en) * | 1980-02-25 | 1981-03-10 | Gulf Research & Development Company | Preparation of ethylene glycol from ethylene |
| JPS6089422A (ja) * | 1983-10-24 | 1985-05-20 | Kureha Chem Ind Co Ltd | 抗骨粗鬆症剤 |
| US4719204A (en) * | 1984-03-05 | 1988-01-12 | Wisconsin Alumni Research Foundation | Fowl bone mineralization with 28-NOR 1α-hydroxyvitamin D2 analogs |
| US4588716A (en) * | 1984-05-04 | 1986-05-13 | Wisconsin Alumni Research Foundation | Method for treating metabolic bone disease in mammals |
| US4588528A (en) * | 1984-05-31 | 1986-05-13 | Wisconsin Alumni Research Foundation | 1,24-dihydroxy-Δ22 -vitamin D3 and process for preparing same |
| US4822609A (en) * | 1984-12-21 | 1989-04-18 | The Procter & Gamble Company | Treatment of osteoporosis |
| US4833125A (en) * | 1986-12-05 | 1989-05-23 | The General Hospital Corporation | Method of increasing bone mass |
| US5001118A (en) * | 1986-12-29 | 1991-03-19 | Kureha Kagaku Kogyo Kabushiki Kaisha | Method for preventing senescence and increasing bone mass |
| US4997824A (en) * | 1987-07-22 | 1991-03-05 | Teva Pharmaceutical Industries Ltd. | Combination of cholecalciferol derivatives for the treatment of renal bone disease |
| US5104864A (en) * | 1988-08-02 | 1992-04-14 | Bone Care International, Inc. | Method for treating and preventing loss of bone mass |
| CA2010982C (en) * | 1989-02-28 | 2000-06-13 | Toshio Matsumoto | Osteogenesis promotion with use of vitamin d derivatives |
-
1993
- 1993-04-13 AU AU36891/93A patent/AU666529B2/en not_active Ceased
- 1993-04-15 NZ NZ247406A patent/NZ247406A/xx unknown
- 1993-04-20 CA CA002094424A patent/CA2094424C/en not_active Expired - Fee Related
- 1993-04-21 IL IL105475A patent/IL105475A/xx not_active IP Right Cessation
- 1993-04-23 JP JP5119276A patent/JP2769960B2/ja not_active Expired - Lifetime
- 1993-04-23 KR KR1019930006847A patent/KR940005275A/ko not_active Ceased
- 1993-04-26 EP EP93303249A patent/EP0567352B1/de not_active Expired - Lifetime
- 1993-04-26 DE DE69301750T patent/DE69301750T2/de not_active Expired - Fee Related
- 1993-04-26 AT AT93303249T patent/ATE135220T1/de not_active IP Right Cessation
-
1994
- 1994-01-12 US US08/180,105 patent/US5395830A/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| ATE135220T1 (de) | 1996-03-15 |
| NZ247406A (en) | 1999-05-28 |
| JP2769960B2 (ja) | 1998-06-25 |
| KR940005275A (ko) | 1994-03-21 |
| DE69301750T2 (de) | 1996-07-25 |
| DE69301750D1 (de) | 1996-04-18 |
| AU666529B2 (en) | 1996-02-15 |
| IL105475A0 (en) | 1993-08-18 |
| CA2094424A1 (en) | 1993-10-25 |
| US5395830A (en) | 1995-03-07 |
| EP0567352A1 (de) | 1993-10-27 |
| AU3689193A (en) | 1993-10-28 |
| JPH0624992A (ja) | 1994-02-01 |
| EP0567352B1 (de) | 1996-03-13 |
| CA2094424C (en) | 2001-01-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TW366342B (en) | The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss | |
| AU2711295A (en) | Combination treatment for inhibiting bone loss | |
| WO1994027589A3 (en) | Antidepressant dosage form | |
| GB9410987D0 (en) | High dosage pharmaceutical compositions | |
| AU2553992A (en) | Bone-growth-stimulating composition | |
| PL303937A1 (en) | Application of an antiestrogen compound and pharmaceutical agent | |
| MX9704030A (es) | 1,1-dioxidos de 2-heterocicliloxi y tiometil-1,2,5-tiadiazolidin-3-ona y composiciones y metodo de uso de los mismos. | |
| UA41355C2 (uk) | Засіб для лікування нейро-сніду | |
| IL105475A (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING 1a, 24(R) - DIHYDROXY-22(E)-DEHYDRO- VITAMIN D3 FOR TREATING OSTEOPOROSIS | |
| AU1430492A (en) | Pharmaceutical composition for the treatment of gastritis | |
| AU1866888A (en) | Pharmaceutical dosage unit containing 17beta-oestradiol and desogestrel | |
| IL101245A0 (en) | Pharmaceutical compositions for the treatment of prostatic cancer | |
| CA2135709A1 (en) | Melatonin derivatives for use in treating sleep disorders | |
| CA2135710A1 (en) | Melatonin derivatives for use in treating desynchronization disorders | |
| IL111805A0 (en) | Pharmaceutical compositions comprising dimeticone for the treatment of aphthae | |
| AU7812794A (en) | Pharmaceutical compositions containing n-acetylcarnosine for the treatment of cataract | |
| IL105474A0 (en) | Pharmaceutical compositions containing 1alpha,25-dihydroxy-22(e)-dehydrovitamin d3 for treating osteoporosis | |
| AU1188492A (en) | Pharmaceutical combination for the prevention and treatment of postmenopausal osteoporosis | |
| TW330933B (en) | Furanoeremophilane and eremophilanolide sesquiterpenes for treatment of diabetes | |
| IL111144A0 (en) | Pharmaceutical compositions containing amiodarone for the treatment of heart failure | |
| IL110780A0 (en) | Pharmaceutical compositions containing 1,3-bis(2-carboxy-chromon-5-yloxy)-propan-2-ol for the treatment of the common cold | |
| EP0618812A4 (de) | Verwendung von protease nexin-i als mittel gegen entzündungen. | |
| IL99666A0 (en) | Pharmaceutical compositions for the treatment of diabetes | |
| CA2136140A1 (en) | Carcinostatic for hormonotherapy containing dienogest as effective component | |
| IL105690A0 (en) | Pharmaceutical compositions for the treatment of arrhythmia |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| RH1 | Patent not in force |